Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1982 1
1983 1
1991 1
1995 2
1997 1
1998 1
1999 1
2003 1
2005 1
2006 2
2007 1
2008 1
2009 1
2010 1
2015 1
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year
Filters applied: . Clear all
Page 1
Idiopathic distal sensory polyneuropathy: ACTTION diagnostic criteria.
Freeman R, Gewandter JS, Faber CG, Gibbons C, Haroutounian S, Lauria G, Levine T, Malik RA, Singleton JR, Smith AG, Bell J, Dworkin RH, Feldman E, Herrmann DN, Hoke A, Kolb N, Mansikka H, Oaklander AL, Peltier A, Polydefkis M, Ritt E, Russell JW, Sainati S, Steiner D, Treister R, Üçeyler N. Freeman R, et al. Among authors: sainati s. Neurology. 2020 Dec 1;95(22):1005-1014. doi: 10.1212/WNL.0000000000010988. Epub 2020 Oct 14. Neurology. 2020. PMID: 33055271 Free PMC article. Review.
Pentoxifylline and diabetic neuropathy.
Sainati SM. Sainati SM. Diabetes Care. 1991 Oct;14(10):930. doi: 10.2337/diacare.14.10.930a. Diabetes Care. 1991. PMID: 1812883 Clinical Trial. No abstract available.
Valdecoxib, a COX-2-specific inhibitor, does not affect cardiac repolarization.
Sarapa N, Britto MR, Cotton B, Cox SR, Francom SF, Jin N, Polasek ED, Sainati SM, Crosby-Sessoms SL, Fleishaker JC. Sarapa N, et al. Among authors: sainati sm. J Clin Pharmacol. 2003 Sep;43(9):974-82. doi: 10.1177/0091270003257220. J Clin Pharmacol. 2003. PMID: 12971029 Clinical Trial.
17 results